We’re excited to see Arduino enter a new chapter with its acquisition by Qualcomm, a milestone that brings together Arduino’s open-source innovation and global community with Qualcomm’s leadership in high-performance computing, connectivity, and AI.
This acquisition represents a major step forward for developers, educators, and enterprises worldwide. It preserves Arduino’s independence and open-source ethos while providing the resources, technology, and reach to accelerate its mission of making advanced computing and creation accessible to everyone.
The newly announced Arduino UNO Q, powered by Qualcomm’s Dragonwing™ processor, bridges real-time control with advanced AI capabilities—while Arduino App Lab unifies development across Real-time OS, Linux, Python, and AI, making it easier than ever for millions of developers to create intelligent systems at the edge.
As investors and long-time users + supporters of Arduino, Anzu Partners is proud to have helped enable this journey. We believe this acquisition positions Arduino to empower its 33-million-strong community with unprecedented tools for innovation while ensuring that open, accessible, and community-driven engineering continues to thrive.
We look forward to seeing what Fabio Violante, Massimo Banzi, Pietro Dore, and the combined Arduino and Qualcomm teams will build together in this next era of innovation.
Sincerely,
Jimmy Kan, Partner at Anzu Partners
Whitney Haring-Smith, Managing Partner at Anzu Partners
PORTFOLIO COMPANY UPDATES
Niron Magnetics Breaks Ground on Rare-Earth Free Magnet Facility and Licenses New Motor Design Patents
Niron Magneticsbroke ground on a new state-of-the-art 1,500-ton-per-year permanent magnet manufacturing facility in Sartell, Minnesota. After nearly a decade of research and development in partnership with the U.S. Department of Energy and the University of Minnesota, Niron Magnetics has successfully created one of the first commercially viable new magnet materials in decades. The groundbreaking marks a major milestone in Niron Magnetics’ ability to scale manufacturing of permanent magnets made from Iron Nitride, which exhibits high magnetization and removes the need for rare-earth elements.
The new 190,000-square-foot facility will expand Niron Magnetics’ capacity to supply rare-earth-free permanent magnets for data center cooling pumps, automobile motors, robotics, consumer electronics, defense and drone equipment, and other applications critical to the U.S. economy. The plant will be operational in early 2027 and will create over 175 full-time jobs in manufacturing, engineering, and operations.
XGS Energy Announced 3000-Hour Operations Milestone for Water-Independent Geothermal System
XGS Energy, a developer of next-generation geothermal power projects leveraging a proprietary water-independent technology system, announced the successful operation of its geothermal system at commercial scale for over 3000 hours, proving commercial economics. XGS is the first company to demonstrate a water-independent geothermal system at commercial conditions and scale. Operations were completed at the Coso geothermal field owned by Atlantica Sustainable Infrastructure and operated by Coso Operating Company, located in the Western Mojave Desert region of California.
“This project demonstrates we are not only able to leverage TRE to produce geothermal energy at commercial scale, but also that we can substantially shorten well construction times to deliver large-scale power projects faster,” said Dr. Ghazal Izadi, XGS Chief Operating Officer. “With strong demonstrated performance of the TRE system, we can turn our focus to more traditional value drivers such as well design, drilling speed and surface plant cost, leveraging best practices from the oil and gas industry to deliver cost advantage at scale.”
Xendee Raised Series B Financing and Announced Collaboration with Eaton
Xendee Corporation, a provider of a leading design and operation platform for distributed energy and microgrid systems, announced a collaboration with Eaton, an intelligent power management company. Eaton also led a Series B financing round for Xendee to further accelerate the deployment of artificial intelligence (AI) powered tools for distributed energy resources (DERs), and to help power the next phase of Xendee’s growth. Together, the companies will provide customers a streamlined path to design, deploy and operate highly efficient, resilient microgrids and DERs.
The collaboration couples Eaton microgrid hardware and engineering service capabilities with Xendee’s AI-powered Model Predictive Control software, which continually evaluates and optimizes microgrid systems with AI forecasted alternatives. Xendee’s solution is hardware agnostic, allowing DER operators to seamlessly manage over 27 different types of technologies, including solar, battery energy storage systems, nuclear, linear generators, and combined heat and power.
Azumo Announced Strategic Partnership with Cymmetrik
Azumo, the developer of reflective display lightguide technologies, andCymmetrik Group, a leading global provider of printing applications and value-added services, announced a comprehensive strategic partnership that will redefine manufacturing for next-generation display and lighting applications across Industrial, Automotive, and Consumer Electronics markets.
Azumo will now manufacture using its proprietary equipment, state of the art front flights for displays, at Cymmetrik’s ISO-certified facilities, including a newly built clean room in Santa Teresa, New Mexico, ensuring automotive compliance (IATF 16949) and industrial-scale capacity.
BioFlyte Partnered with Los Alamos National Laboratory to Optimize Modeling and Simulation Tools for Biothreat Detection and Response
BioFlyte, a chemical and bioaerosol surveillance firm with a disruptive new class of fieldable chemical and biological threat collection, detection, and identification solutions, announced a new collaboration with Los Alamos National Laboratory (LANL) as part of the New Mexico Technology Readiness Gross Receipts (TRGR) initiative. The project will accelerate the development of an advanced indoor aerosol modeling tool using LANL’s renowned QUIC (Quick Urban & Industrial Complex) software.
“Modifying QUIC for indoor environments means we can simulate real-world aerosol dispersion and optimize accurate sensor placement and overall solution architecture much quicker, in most cases reducing these analyses from weeks to days,” said Todd Sickles, CEO of BioFlyte. “We look forward to collaborating with LANL, who brings unique capabilities to this project, with the result being a significant advantage in the growing biodefense and public safety markets.”
Zeteo Tech Awarded $1M from CARB-X to Support Lower Respiratory Tract Infection Diagnostic
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has awarded Zeteo Tech, Inc. US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections (LRTIs) in high-risk populations within critical care environments, including intubated patients with mechanical ventilation.
“We are thrilled to have been selected for this award, which represents a strong vote of confidence in our team, our technology, and our commitment to excellence,” said Wayne Bryden, PhD, CEO of Zeteo in the press release. “This funding will be crucial in advancing BreathBiomics™ and accelerating our ability to deliver real-world solutions.We’re excited to get started and look forward to a successful collaboration with our partners.”
Excision BioTherapeutics Announced Positive Preclinical Data from its Hepatitis B virus (HBV) EBT-107 Program
Excision BioTherapeutics, Inc., a biotechnology company developing CRISPR-based therapies to cure serious latent viral infectious diseases, announced that positive preclinical data from its Hepatitis B virus (HBV) EBT-107 program were presented at the 6th ICE-HBV “HBV Cure Symposium” which took place on September 12, 2025, in Berlin, Germany.
Chronic hepatitis B caused by infection of hepatitis B virus (HBV) is one of the most prevalent infectious diseases worldwide that lacks curative therapies. While existing antiviral and immunomodulator treatments slow progression of liver disease by reducing viral load, they fail to eliminate covalently closed circular DNA (cccDNA) that enables persistent viral infection. Excision’s lead product candidate for the treatment of HBV infection, EBT-107, uses dual guide RNAs to excise large sections of viral DNA and effectively deactivate the virus.
NTx Strengthened Leadership with Appointment of Dave Johnson to Board of Directors and Dr. Jeff Coller to Scientific Advisory Board
NTx, a life sciences company developing next-generation platforms for RNA and protein manufacturing, announced the addition of two distinguished leaders to its governance and advisory bodies. Dave Johnson, a globally recognized corporate strategist with deep expertise in mergers, acquisitions, and corporate development, has joined the company’s Board of Directors. In parallel, NTx appointed Dr. Jeff Coller, Bloomberg Distinguished Professor of RNA Biology and Therapeutics at Johns Hopkins University, to its Scientific Advisory Board (SAB).
Dave Johnson, Board of Directors Dave Johnson is a globally recognized leader in M&A and corporate strategy, with more than 120 acquisitions representing over $40 billion in equity investment, divestitures, and venture capital transactions.
Jeff Coller, Ph.D., Scientific Advisory Board Dr. Jeff Coller is a leading authority in RNA and mRNA biology and currently serves as Bloomberg Distinguished Professor of RNA Biology and Therapeutics at Johns Hopkins University. His pioneering research on mRNA stability and translation has reshaped the understanding of gene expression and contributed to the development of mRNA vaccines, including SPIKEVAX.
Anzu Partners was proud to sponsor an event at New York Climate Week in Hudson Yards, featuring Anzu portfolio company XGS Energy. The panel on Scaling Power Infrastructure was co-sponsored by J.P. Morgan, Aligned Climate Capital, Constellation Energy, and BCG. Thank you to all the investors and entrepreneurs who attended!
Upcoming Events
Anzu representatives plan to attend the following events:
LA Tech Week – October 13-19, 2025 – Los Angeles, CA
XGS Energy was featured in The Cool Down for its geothermal energy technology.
Niron Magnetics was featured in Drives & Controls for its rare-earth free magnet technology. Niron’s CEO Jonathan Rowntree also appeared on an episode of the Crossing The Valley podcast to discuss its technology.
Xendee co-founder and CTO Dr. Michael Stadler contributed a piece on energy storage to North American Clean Energy.
e-Zinc was featured in a POWER Magazine piece on storage technologies and the energy transition. e-Zinc was also the subject of a CleanTechnica piece on how zinc air batteries can help solve US energy storage problems.
MedCrypt’s vice president of regulatory strategy Naomi Schwartz and chief security strategist Axel Wirth contributed a piece on the FDA’s absence on standards to STAT News*. MedCrypt was also included in Becker’s Health IT’s list of healthcare cybersecurity companies to know.
Aspinity was featured in a Tech Announcer piece on analog computing.
*Requires subscription to read
Join Our Ecosystem
Anzu Partners and our portfolio companies are growing, and we’re always looking for exceptional talent. Whether you're seeking new career opportunities or exploring ways to collaborate, we invite you to connect with us and become part of our network.
To stay up to date on the latest news from both Anzu and our portfolio companies, follow us on social media.
ABOUT ANZU PARTNERS
Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industries. Anzu works with entrepreneurs to develop and commercialize technological innovations by providing capital alongside deep expertise in business development, market positioning, intellectual property, global connectivity, and operations. For more information, please visit https://anzupartners. com/.
The information contained in this newsletter is being provided by Anzu Partners for informational purposes only. The information was obtained from various sources, but Anzu Partners cannot assure its accuracy. This is neither an offer to sell nor a solicitation for an offer to buy an interest in any fund managed by Anzu Partners. Any such offer or solicitation will only be made to qualified potential investors pursuant to a private placement memorandum. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.
You are receiving this email because you requested to be added to Anzu Partners' monthly newsletter distribution list.
